CLIAC Waiver Criteria Input Readied As FDA Gears Up To Draft Guidance
This article was originally published in The Gray Sheet
Executive Summary
The Clinical Laboratory Improvement Advisory Committee is close to issuing waiver recommendations, after agreeing to largely adopt criteria developed by its CLIA waiver workgroup